Use of metolazone, a new diuretic, in patients with renal disease.
D000284:Administration, Oral; D000328:Adult; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000628:therapy; D001786:Blood Glucose / Q000032:analysis; D001794:Blood Pressure; D003404:Creatinine / Q000652:urine; D004232:Diuretics / Q000008:administration & dosage / Q000627:therapeutic use*; D004487:Edema / Q000188:drug therapy; D005260:Female; D005919:Glomerular Filtration Rate; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007275:Injections, Intravenous; D007444:Inulin / Q000652:urine; D007674:Kidney Diseases / Q000188:drug therapy*; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D011188:Potassium / Q000652:urine; D011799:Quinazolines / Q000008:administration & dosage / Q000627:therapeutic use*; D012083:Renin / Q000097:blood; D012964:Sodium / Q000652:urine; D013449:Sulfonamides; D014527:Uric Acid / Q000097:blood
D000959:Antihypertensive Agents; D001786:Blood Glucose; D004232:Diuretics; D011799:Quinazolines; D013449:Sulfonamides; D014527:Uric Acid; D007444:Inulin; D012964:Sodium; D003404:Creatinine; D012083:Renin; D011188:Potassium